26 Aug 2020

ILIAS's new publication provides an overview of the recent advances and highlights in exosome-based therapeutics

Our scientists at ILIAS Biologics Inc. have recently published a review article in a peer-reviewed medical journal, the American Journal of Reproductive Immunology (AJRI).

This publication provides an overview of the recent advances in exosome research and highlights the challenges in bringing the exosome-based therapeutics from bench to bedside.

Various exosome engineering technologies, including ILIAS’s EXPLOR® (EXosome engineering for Protein Loading via Optically Reversible protein-protein interactions), are also compared in the article. 

To learn more about the paper, visit Journal Website.

(Click) “The emerging role of exosomes as novel therapeutics: biology, technologies, clinical applications, and the next.” AJRI, 2020.